The short version
12 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Entacapone
Entacapone · ENTACAPONE 200 mg/1 · Tablet, Film Coated · Oral · Aurobindo Pharma Limited
NDC 65862-0654-99 · 1000 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for entacapone (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- analysis · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA203437
- TE code
- AB
- Approval date
- Jun 19, 2015
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Entacapone (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Alembic Pharmaceuticals Inc. | ENTACAPONE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Alembic Pharmaceuticals Limited | ENTACAPONE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| American Health Packaging | ENTACAPONE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | ENTACAPONE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | ENTACAPONE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AvPAK | ENTACAPONE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Lannett Company, Inc. | ENTACAPONE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Major Pharmaceuticals | ENTACAPONE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Orion Corporation, Orion Pharma | ENTACAPONE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rising Pharma Holdings, Inc. | ENTACAPONE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sandoz Inc | ENTACAPONE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Sun Pharmaceutical Industries, Inc. | ENTACAPONE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Entacapone — NDC 65862-0654-99," retrieved September 3, 2026, https://drugdashboards.com/drug/65862065499.
Free to cite with attribution — see how the data is put together.